Ghostwriters Used in Biomedical Journals

Court documents show that 26 scientific articles in journals, all about hormone replacement therapy for women, were at least partly ghostwritten by a medical communications company paid by the pharmaceutical company Wyeth, The New York Times reported. The articles suggested a consensus on the value of the therapy, but that apparent consensus has since fallen apart. Eighteen journals published the articles -- without revealing Wyeth's role.